A single-cente retrospective study assessing the efficacy and safety of high Vs standard Daptomycin doses in Chinese patients with severe burn injuries by pharmacokinetic evaluation
Latest Information Update: 14 Sep 2021
At a glance
- Drugs Daptomycin (Primary)
- Indications Burn infections; Gram-positive infections
- Focus Pharmacodynamics; Pharmacokinetics
- 14 Sep 2021 Status changed from not stated to completed.
- 14 Sep 2021 New trial record